Gene · 10057
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemoresistance: The hidden barrier in cancer treatment. | Cancer Pathog Ther | 2026 | 41550358 | PubTator, text mining | PubMed |
| The Dual Role of SLC7A11 in Colorectal Cancer Ferroptosis: From Molecular Mechanisms to Therapeutic Opportunities. | Onco Targets Ther | 2026 | 41531864 | PubTator, text mining | PubMed |
| Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | 37530668 | PubTator, text mining | PubMed |
| The disturbance of ABC transporters in patients with dengue fever: integration of metabolomics and transcriptomics. | Front Cell Infect Microbiol | 2025 | 41756409 | PubTator, text mining | PubMed |
| Impacts of polymorphisms in drug-metabolizing enzyme and transporter genes on irinotecan toxicity and efficacy in Thai colorectal cancer patients. | PLoS One | 2025 | 41385496 | PubTator, text mining | PubMed |
| Targeting of Brahma-related gene-1 (BRG1) overcomes paclitaxel-induced multidrug resistance caused by overexpression of the subset of ATP-binding cassette (ABC) transporters. | J Pharmacol Exp Ther | 2025 | 41371092 | PubTator, text mining | PubMed |
| [Role and Mechanism of Hyaluronic Acid-modified Milk Exosomes in Reversing Pemetrexed Resistance in Lung Adenocarcinoma Cells]. | Zhongguo Fei Ai Za Zhi | 2025 | 41309248 | PubTator, text mining | PubMed |
| HIF1A, BRG1, and p300 interaction confers paclitaxel-induced drug resistance by enabling the overexpression of ABCC genes. | Mol Ther Oncol | 2025 | 41050430 | PubTator, text mining | PubMed |
| An Emerging Paradigm for ABCC5/MRP5 Function in Human Physiology. | Int J Mol Sci | 2025 | 41009771 | PubTator, text mining | PubMed |
| Colorectal Neoplasia Pathogenesis in Normal Appearing Colonic Mucosa -A Perspective With Focus on Eicosanoid Signaling Pathways. | Cancer Med | 2025 | 40980975 | PubTator, text mining | PubMed |
| To explore the prognostic efficacy and mechanism of ABCC5 clinical scoring model in hepatocellular carcinoma. | Front Oncol | 2025 | 40860808 | PubTator, text mining | PubMed |
| Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis. | Front Pharmacol | 2025 | 40741000 | PubTator, text mining | PubMed |
| Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells. | Int J Mol Sci | 2025 | 40649986 | PubTator, text mining | PubMed |
| Identification of a ferroptosis related genes signature and GDF15 contributing to a new perspective for the diagnosis of CRPC. | Sci Rep | 2025 | 40594867 | PubTator, text mining | PubMed |
| Experimental validation and identification of ferroptosis-associated biomarkers for diagnostic and therapeutic targeting in hearing loss. | Front Aging Neurosci | 2025 | 40353062 | PubTator, text mining | PubMed |
| Hyaluronic acid-modified milk exosomes carrying ZNF516 inhibit ABCC5 and contribute to pemetrexed sensitivity in lung adenocarcinoma. | Hum Cell | 2025 | 40253507 | PubTator, text mining | PubMed |
| Genetic Association of Primary Angle-Closure Glaucoma and Disease Progression. | Clin Exp Ophthalmol | 2025 | 40234024 | PubTator, text mining | PubMed |
| Cardiovascular toxicity in patients with oncohematological diseases: genetic predictors study. | Minerva Cardiol Angiol | 2025 | 40152040 | PubTator, text mining | PubMed |
| Prodrug Approach as a Strategy to Enhance Drug Permeability. | Pharmaceuticals (Basel) | 2025 | 40143076 | PubTator, text mining | PubMed |
| Transport of statins by multidrug resistance-associated proteins 1 and 5. | Eur J Pharm Sci | 2025 | 40089121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10057/papers?page=2